Related Experiment Video
Updated: Jul 14, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
[Neonatal outcome in pregnancies complicated with pregestational diabetes mellitus]
Aleksandar Cetković1, Marina Durović
1Klinicki centar Srbije, Institut za ginekologiju i akuserstvo, Beograd. vlatka.c@yubc.net
Insights
Pregnancy with pregestational diabetes mellitus (PGDM) significantly increases the risk of neonatal complications, including macrosomia, birth injuries, and congenital malformations. Optimal maternal glucose control before and during pregnancy is crucial for reducing adverse neonatal outcomes.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Endocrinology
Context:
- Pregestational diabetes mellitus (PGDM) is associated with elevated risks of maternal and neonatal complications.
- Understanding neonatal outcomes in PGDM pregnancies is critical for improving perinatal care.
Purpose:
- To determine neonatal outcomes in pregnancies complicated by pregestational diabetes mellitus.
- To identify factors influencing neonatal outcomes in women with PGDM.
Summary:
- Women with PGDM experienced significantly higher rates of neonatal complications (85%) compared to the control group (15.5%).
- Specific complications included macrosomia, birth injuries, neonatal deaths, and congenital malformations, all more frequent in the PGDM group.
- A strong correlation was found between maternal glycemic control and neonatal outcomes.
Impact:
- Highlights the increased incidence of neonatal morbidity and mortality in PGDM pregnancies.
- Emphasizes the importance of preconception and prenatal glucose management for reducing neonatal complications in women with PGDM.
Background/Aim:
Pregestational diabetes mellitus (PGDM) represents glucose intolerance that begins before pregnancy and is followed by the increased risk of neonatal and maternal complications. The aim of this study was to establish neonatal outcome in pregnancies with pregestational diabetes mellitus and the factors that had influence on it.
Methods:
This study included 27 pregnant women with insulin-dependant PGDM hospitalized during 2004 in the Institute for Obstretics and Gynecology, Clinical Center of Serbia, Belgrade. The control group consisted of 2 292 healthy pregnant women presented to the Institute within 2004.
Results:
Twenty-three (85%) infants of the women with PGDM had complications in comparison with 356 (15.5%) infants of the women in the control group, that was statistically significant difference (p < 0.001). Macrosomia was present in 8 (29.6%/0) and birth injuries in 6 (22.2%) infants of women with PGDM that was statistically significant difference (p < 0.001) in comparisom with the women in the control group who had 194 (8.5%) infants with macrosomia and 156 (6.8%) infants with birth injuries. The women with PGDM had 3 (11.1%) neonatal deaths and 3 (11.1%) infants were born with congenital malformations in comparison with the women in the control group without these complications. We established statisticaly significant correlation (p < 0.001) between glicoregulation before and during pregnancy in the women with PGDM and neonatal outcome.
Conclusion:
The incidence of neonatal morbidity and mortality in the women with PGDM was significantely more frequent as compared with the normal population. Achieving optimal maternal glucose levels in women with PGDM both preconceptionally and during pregnancy is associated with significant reduction of neonatal complications.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Complications of Diabetes Mellitus
Diabetes Mellitus: Introduction
Diabetes: Symptoms, Diagnosis, and Complications
Diabetic Retinopathy
